Celanese Corporation News
Celanese Corporation, a chemical and specialty materials company, manufactures and sells high performance engineered polymers in the United States and internationally. The company operates through Engineered Materials and Acetyl Chain. The Engineered Materials segment develops, produces, and supplies specialty polymers for automotive and medical applications, as well as for use in industrial products and consumer electronics. It also offers acesulfame potassium for the food and beverage industry, and food protection ingredients, such as potassium sorbate and sorbic acid. The Acetyl Chain segment produces and supplies acetyl products, including acetic acid, vinyl acetate monomers, acetic anhydride, and acetate esters that are used as starting materials for colorants, paints, adhesives, coatings, and pharmaceuticals; and organic solvents and intermediates for pharmaceutical, agricultural, and chemical products. It also offers vinyl acetate-based emulsions for use in paints and coatings, adhesives, construction, glass fiber, textiles, and paper applications; and ethylene vinyl acetate resins and compounds, as well as low-density polyethylene for use in flexible packaging films, lamination film products, hot melt adhesives, automotive parts, and carpeting applications. In addition, it manufactures ultra-high molecular weight polyethylene. Celanese Corporation was founded in 1918 and is headquartered in Irving, Texas.
see moreCelanese Corporation Market News
6d
Celanese Sells Micromax; Targets Debt, Cuts Costs.
- Celanese completed the Micromax divestiture, boosting liquidity for debt reduction while reporting softer volumes in acetyl and engineered materials. Cost cuts, plant closure plans and a $700–$800M free cash flow target shape near-term CE stock outlook.
20d
Celanese $500M Micromax Deal Boosts Deleveraging!!
Celanese completed the sale of its Micromax business for roughly $500 million, a concrete step toward reducing its elevated leverage. Despite the cash infusion, shares slipped on Feb. 23 as investors remained cautious; lower trading volume and broader weakness left CE underperforming peers. The divestiture improves near-term liquidity and should be monitored for its impact on debt paydown, interest coverage and free cash flow.
27d
Celanese Debt Cuts and FCF Surge Fuel CE Rally Now
Celanese’s latest quarter showed a sharp operating recovery but missed EPS and revenue expectations. Concrete actions — $4B debt refinancing, $773M FY free cash flow, planned asset sales, and targeted cost and working-capital reductions — strengthen liquidity and drive near-term investor focus. Improved technical indicators add a possible upside catalyst if execution continues.
16 Feb at 04:13
Celanese Price Hikes and $0.03 Dividend Signal Now
Celanese (NYSE: CE) announced a $0.03 quarterly dividend and targeted price increases of $50–$100/MT across key acetate and ester product lines in the Americas. Those concrete moves aim to offset elevated feedstock costs and shore up margins as specialty-chemical peers face persistent EBITDA pressure and rising leverage. The actions are a clear signal of pricing power and capital-allocation discipline for S&P 500-listed Celanese.
09 Feb at 04:14
Chemours Surges After RS Upgrade; Earnings Set Now
Chemours (CC) recently hit an RS Rating of 83 and broke above a 16.58 handle, sparking a >5% move. With Q4 2025 results scheduled for Feb 19–20, 2026 and recent weak fundamentals, investors face a tension between technical momentum and operational headwinds.